Phospholamban: A Prominent Regulator of Myocardial Contractility
- 1 December 1996
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 79 (6), 1059-1063
- https://doi.org/10.1161/01.res.79.6.1059
Abstract
Our understanding of the role of phospholamban in cardiac physiology has evolved over the past two decades to the point where this protein is now understood to be a critical repressor of myocardial contractility. Phospholamban, through its inhibitory effects on the affinity of the cardiac sarcoplasmic reticulum Ca2+ pump for Ca2+, represses both the rates of relaxation and contraction in the mammalian heart. These inhibitory effects can be relieved through (1) phospholamban phosphorylation, (2) down-regulation of phospholamban gene expression, and (3) disruption of the phospholamban-Ca(2+)-ATPase interaction. Thus, genetic approaches and pharmacological interventions, designed to relieve the phospholamban inhibitory action on the cardiac sarcoplasmic reticulum Ca2+ pump and myocardial relaxation, may prove valuable in reversing the effects of several diseases in the mammalian heart. Such interventions could be designed to inhibit the phospholamban phosphatase, stabilize the phosphorylated state of phospholamban, interrupt the phospholamban-Ca(2+)-ATPase interaction, decrease phospholamban transcription, or disrupt phospholamban mRNA stability. Development of such therapeutic strategies to target phospholamban will be an important future goal for the clinical improvement of contractility in the failing heart.Keywords
This publication has 27 references indexed in Scilit:
- Messenger RNA expression and immunological quantification of phospholamban and SR-Ca2+-ATPase in failing and nonfailing human heartsCardiovascular Research, 2000
- A Leucine Zipper Stabilizes the Pentameric Membrane Domain of Phospholamban and Forms a Coiled-coil Pore StructureJournal of Biological Chemistry, 1996
- Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.JCI Insight, 1996
- Solution structure of the cytoplasmic domain of phospholamban: phosphorylation leads to a local perturbation in secondary structureBiochemistry, 1995
- cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardiumCardiovascular Research, 1994
- The hydrophilic domain of phospholamban inhibits the Ca2+ transport step of the Ca2+-ATPaseBiochemical Journal, 1994
- The physical mechanism of calcium pump regulation in the heartBiophysical Journal, 1994
- Phosphorylation of C-protein, troponin I and phospholamban in isolated rabbit heartsBiochemical Journal, 1988
- Dissociation between contraction and relaxation: The possible role of phospholamban phosphorylationBasic Research in Cardiology, 1987
- Regulation of Ca2+ transport by cyclic 3′,5′-AMP-dependent and calcium-calmodulin-dependent phosphorylation of cardiac sarcoplasmic reticulumBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1985